These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19551826)

  • 1. Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B.
    Borgniet O; Parvaz P; Bouix C; Chevallier P; Trépo C; André P; Zoulim F
    J Med Virol; 2009 Aug; 81(8):1336-42. PubMed ID: 19551826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Persistence of hepatitis B virus in children after interferon-alpha therapy despite the seroconversion in HBsAg/anti-HBs system].
    Gregorek H; Dzierzanowska-Fangrat K; Woynarowski M; Jóźwiak P; Witkowska-Vogtt E; Wojda U; Syczewska M; Socha J; Madalińiski K
    Przegl Epidemiol; 2005; 59(3):641-9. PubMed ID: 16433306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of HBV-DNA in children with chronic hepatitis B who seroconverted to anti-HBs antibodies after interferon-alpha therapy: correlation with specific IgG subclass responses to HBsAg.
    Gregorek H; Dzierzanowska-Fangrat K; Woynarowski M; Jóźwiak P; Witkowska-Vogtt E; Socha J; Syczewska M; Madaliński K
    J Hepatol; 2005 Apr; 42(4):486-90. PubMed ID: 15763334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine.
    Kobayashi M; Suzuki F; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Yatsuji H; Kobayashi M; Suzuki Y; Arase Y; Ikeda K; Watahiki S; Iwasaki S; Miyakawa Y; Kumada H
    J Med Virol; 2007 Oct; 79(10):1472-7. PubMed ID: 17705186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of lamivudine-induced HBsAg loss rate according to age in children with chronic hepatitis B].
    Kim JM; Choe BH; Chu MA; Cho SM
    Korean J Hepatol; 2009 Jun; 15(2):168-78. PubMed ID: 19581769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients.
    Boyd A; Canini L; Gozlan J; Lascoux-Combe C; Miailhes P; Fonquernie L; Girard PM; Lacombe K
    J Clin Virol; 2017 Oct; 95():55-60. PubMed ID: 28869890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of hepatitis B virus (HBV) vaccination in treating lamivudine-resistant HBV reactivation following hepatitis B surface antigen seroconversion.
    Gérolami R; Borentain P; Colson P; Norguet E; Gérolami A; Tamalet C
    Liver Int; 2007 Dec; 27(10):1417-21. PubMed ID: 18036104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues.
    Jaroszewicz J; Ho H; Markova A; Deterding K; Wursthorn K; Schulz S; Bock CT; Tillmann HL; Manns MP; Wedemeyer H; Cornberg M
    Antivir Ther; 2011; 16(6):915-24. PubMed ID: 21900724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B.
    Su TH; Hsu CS; Chen CL; Liu CH; Huang YW; Tseng TC; Liu CJ; Chen PJ; Lai MY; Chen DS; Kao JH
    Antivir Ther; 2010; 15(8):1133-9. PubMed ID: 21149920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in serum hepatitis B surface antigen level and its clinical significance in treatment-naïve, hepatitis B e antigen-positive patients receiving entecavir.
    Jung YK; Kim JH; Lee YS; Lee HJ; Yoon E; Jung ES; Hong SK; Joo MK; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
    J Clin Gastroenterol; 2010 Oct; 44(9):653-7. PubMed ID: 20216430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers.
    Colson P; Borentain P; Motte A; Henry M; Moal V; Botta-Fridlund D; Tamalet C; Gérolami R
    Virology; 2007 Oct; 367(1):30-40. PubMed ID: 17573090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serial study of detection of serum HBV-DNA in chronic hepatitis B patients with clearance of HBs antigen followed by emergence of anti-HBs antibody].
    Kato J; Hasegawa K; Hayashi N
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):569-73. PubMed ID: 12442446
    [No Abstract]   [Full Text] [Related]  

  • 15. A patient with chronic hepatitis B and regression of fibrosis during treatment.
    Chang CY; Martin P; Fotiadu A; Hytiroglou P
    Semin Liver Dis; 2010 Aug; 30(3):296-301. PubMed ID: 20665381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis B virus reactivation during chlorambucil and prednisolone treatment in an HBsAg-negative and anti-HBs-positive patient with B-cell chronic lymphocytic leukemia].
    Lim SM; Jang JW; Kim BW; Choi H; Choi KY; Park SJ; Han CW
    Korean J Hepatol; 2008 Jun; 14(2):213-8. PubMed ID: 18617769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.
    Lukhwareni A; Burnett RJ; Selabe SG; Mzileni MO; Mphahlele MJ
    J Med Virol; 2009 Mar; 81(3):406-12. PubMed ID: 19152393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: a review.
    Liaw YF
    Hepatology; 2011 Jun; 53(6):2121-9. PubMed ID: 21503943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes.
    Chevaliez S; Pawlotsky JM
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1031-48. PubMed ID: 19187865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBsAg plasma level kinetics: a new role for an old marker as a therapy response predictor in vertically infected children on combination therapy.
    Carey I; Bruce M; Horner M; Zen Y; D'Antiga L; Bansal S; Vergani D; Mieli-Vergani G
    J Viral Hepat; 2015 Apr; 22(4):441-52. PubMed ID: 25278170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.